BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 35999434)

  • 1. Intrathecal therapy for the management of leptomeningeal metastatic disease: a scoping review of the current literature and ongoing clinical trials.
    Palmisciano P; Watanabe G; Conching A; Ogasawara C; Vojnic M; D'Amico RS
    J Neurooncol; 2022 Oct; 160(1):79-100. PubMed ID: 35999434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review on the Efficacy and Safety of Intrathecal Administration of Novel Medications for Leptomeningeal Metastases in Solid Cancers.
    Jafari F; Nodeh MM; Hosseinjani H; Baharara H; Azad S; Arasteh O; Johnston TP; Sahebkar A
    Curr Med Chem; 2024; 31(19):2732-2750. PubMed ID: 37157199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.
    Kingston B; Kayhanian H; Brooks C; Cox N; Chaabouni N; Redana S; Kalaitzaki E; Smith I; O'Brien M; Johnston S; Parton M; Noble J; Stanway S; Ring A; Turner N; Okines A
    Breast; 2017 Dec; 36():54-59. PubMed ID: 28968585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review.
    Singh E; Gurses ME; Costello MC; Berke C; Lu VM; Daggubati L; Komotar RJ; Ivan ME; Shah AH
    J Neurooncol; 2024 Mar; 167(1):39-47. PubMed ID: 38294637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast leptomeningeal disease: a review of current practices and updates on management.
    Figura NB; Rizk VT; Armaghani AJ; Arrington JA; Etame AB; Han HS; Czerniecki BJ; Forsyth PA; Ahmed KA
    Breast Cancer Res Treat; 2019 Sep; 177(2):277-294. PubMed ID: 31209686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A; Rudnicka H; Murawska M
    Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for leptomeningeal disease in breast cancer.
    Bartsch R; Jerzak KJ; Larrouquere L; Müller V; Le Rhun E
    Cancer Treat Rev; 2024 Jan; 122():102653. PubMed ID: 38118373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalities.
    Chorti E; Kebir S; Ahmed MS; Keyvani K; Umutlu L; Kanaki T; Zaremba A; Reinboldt-Jockenhoefer F; Knispel S; Gratsias E; Roesch A; Ugurel S; Scheffler B; Schadendorf D; Livingstone E; Meier F; Glas M; Zimmer L
    Eur J Cancer; 2021 May; 148():395-404. PubMed ID: 33789203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole brain radiotherapy combined with intrathecal liposomal cytarabine for leptomeningeal metastasis-a safety analysis and validation of the EANO-ESMO classification.
    Iglseder S; Nowosielski M; Bsteh G; Muigg A; Heugenhauser J; Mayer E; Grams A; Stockhammer G; Nevinny-Stickel M
    Strahlenther Onkol; 2022 May; 198(5):475-483. PubMed ID: 35267049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal methotrexate in combination with systemic chemotherapy in glioblastoma patients with leptomeningeal dissemination: A retrospective analysis.
    Kang X; Chen F; Yang SB; Wang YL; Qian ZH; Li Y; Lin H; Li P; Peng YC; Wang XM; Li WB
    World J Clin Cases; 2022 Jun; 10(17):5595-5605. PubMed ID: 35979103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma.
    Piña Y; Yadugiri S; Yeboa DN; Ferguson SD; Forsyth PA; Oliva ICG
    Curr Oncol Rep; 2022 Jan; 24(1):43-54. PubMed ID: 35059999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
    Mrugala MM; Kim B; Sharma A; Johnson N; Graham C; Kurland BF; Gralow J
    Clin Breast Cancer; 2019 Oct; 19(5):311-316. PubMed ID: 31175053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).
    Ferguson SD; Bindal S; Bassett RL; Haydu LE; McCutcheon IE; Heimberger AB; Li J; O'Brien BJ; Guha-Thakurta N; Tetzlaff MT; Tawbi H; Davies MA; Glitza IC
    J Neurooncol; 2019 May; 142(3):499-509. PubMed ID: 30847840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases.
    Chamberlain MC; Kormanik PA; Barba D
    J Neurosurg; 1997 Nov; 87(5):694-9. PubMed ID: 9347977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
    Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
    Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy in Leptomeningeal Disease: A Systematic Review of Randomized and Non-randomized Trials.
    Buszek SM; Chung C
    Front Oncol; 2019; 9():1224. PubMed ID: 31803614
    [No Abstract]   [Full Text] [Related]  

  • 17. Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution.
    Mandel JJ; Yust-Katz S; Cachia D; Wu J; Liu D; de Groot JF; Yung AW; Gilbert MR
    J Neurooncol; 2014 Dec; 120(3):597-605. PubMed ID: 25168214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptomeningeal disease.
    Groves MD
    Neurosurg Clin N Am; 2011 Jan; 22(1):67-78, vii. PubMed ID: 21109151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cesium-131 brachytherapy in brain tumors: a scoping review of the literature and ongoing clinical trials.
    Palmisciano P; Haider AS; Balasubramanian K; D'Amico RS; Wernicke AG
    J Neurooncol; 2022 Aug; 159(1):117-133. PubMed ID: 35696019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of patients with meningeal carcinomatosis.
    Nakagawa H; Murasawa A; Kubo S; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
    J Neurooncol; 1992 May; 13(1):81-9. PubMed ID: 1613540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.